Triple therapy with sucralfate, tetracycline, and metronidazole for Helicobacter pylori-associated duodenal ulcers.

Joseph J.�y. Sung, Vincent K S Leung, S.C.Sydney Chung, Thomas K.�w. Ling, R Suen, A. F. B. Cheng, Arthur K.c. LiPubMed 1995

Abstract

Therapy of sucralfate, tetracycline, and metronidazole for 1 wk has a satisfactory but lower success rate in eradication of H. pylori when compared with the conventional triple therapy plus omeprazole. Side effects of this therapy are no fewer than the conventional triple therapy.
BibTeX
@inproceedings{sung1995triple,
  author = {Joseph J.�Y. Sung and Vincent K S Leung and S.C.Sydney Chung and Thomas K.�W. Ling and R Suen and A. F. B. Cheng and Arthur K.C. Li},
  title = {{Triple therapy with sucralfate, tetracycline, and metronidazole for Helicobacter pylori-associated duodenal ulcers.}},
  booktitle = {PubMed},
  year = {1995},
}

Loading related content...

Figure